4.5 Article

The effect of ex vivo lung perfusion on microbial load in human donor lungs

Journal

JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 33, Issue 9, Pages 910-916

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2013.12.023

Keywords

lung transplantation; ex vivo lung perfusion; antibiotics; fungicides; donor lung; microbiology

Funding

  1. United Kingdom Cystic Fibrosis Trust
  2. Cystic Fibrosis Trust [PJ556] Funding Source: researchfish
  3. National Institute for Health Research [10/82/01] Funding Source: researchfish

Ask authors/readers for more resources

BACKGROUND: Ex vivo lung perfusion (EVLP) has emerged as a technique to potentially recondition unusable donor lungs for transplantation. Beneficial effects of EVLP on physiologic function have been reported, but little is known about the effect of normothermic perfusion on the infectious burden of the donor lung. In this study, we investigated the effect of EVLP on the microbial load of human donor lungs. METHODS: Lungs from 18 human donors considered unusable for transplantation underwent EVLP with a perfusate containing high-doge, empirical, broad-spectrum anti-microbial agents. Quantitative cultures of bacteria and fungi were performed on bronchoalveolar lavage fluid from the donor lung before and after 3 to 6 hours of perfusion. The identification of any organisms and changes in number of colony forming units before and after EVLP were assessed and anti-microbial susceptibilities identified. RESULTS: Thirteen out of 18 lungs had positive cultures, with bacterial loads significantly decreasing after EVLP. Yeast loads increased when no anti-fungal treatment was given, but were reduced when prophylactic anti-fungal treatment was added to the circuit. Six lungs were ultimately transplanted into patients, all of whom survived to hospital discharge. There was 1 death at 11 months. CONCLUSIONS: Our study shows that EVLP with high-dose, empirical anti-microbial agents in the perfusate is associated with an effective reduction in the microbial burden of the donor lung, a benefit that has not previously been demonstrated. (C) 2014 International Society for Heart and Lung Transplantation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available